Physician profile
Daniel Ramirez
NPI 1316176233
$5,960.48
in general payments reported to CMS, 2019-2025
50 companies · $947 in 2025
The $947 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $944 · 2020: $482 · 2021: $769 · 2022: $985 · 2023: $1,005 · 2024: $828 · 2025: $947.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,439 · Travel and Lodging: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,439.39 |
| Travel and Lodging | $340.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $706.58 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $471.55 | 2021-2025 | Prolaris |
| Astellas Pharma US INC | $466.58 | 2019-2023 | Veozah |
| Coloplast Corp | $405.61 | 2021-2024 | Speedicath |
| Neotract INC. | $402.97 | 2019 | |
| Procept Biorobotics Corporation | $370.67 | 2023-2025 | Aquabeam Robotic System |
| Axonics, INC. | $215.92 | 2020-2024 | Axonics |
| Ferring Pharmaceuticals INC. | $193.94 | 2019-2025 | Adstiladrin |
| Boston Scientific Corporation | $177.77 | 2019-2025 | Spaceoar Vue System - 10ml, Axonics, Tria Firm |
| Abbvie INC. | $150.88 | 2023-2025 | |
| C. R. Bard, INC. & Subsidiaries | $149.97 | 2019-2022 | |
| Myovant Sciences INC. | $142.62 | 2021-2022 | |
| Janssen Biotech, INC. | $138.29 | 2019-2020 | |
| Urogen Pharma, INC. | $113.67 | 2021-2025 | |
| Janssen Scientific Affairs, LLC | $112.93 | 2019 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.